Protection of neonatal mice from lethal enterovirus 71 infection by maternal immunization with attenuated Salmonella enterica serovar Typhimurium expressing VP1 of enterovirus 71

Microbes and Infection

Volumn 8, Issue 7, 2006, Pages 1671-1678

  Chiu, Cheng Hsun ^a   Chu, Chishih ^b   He, Chao Che ^a   Lin, Tzou Yien ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b NATIONAL CHIAYI UNIVERSITY   (Taiwan)

Author keywords

Attenuated Salmonella enterica serovar Typhimurium; Enterovirus 71; VP1 vaccine

Indexed keywords

LIVE VACCINE; PROTEIN VP1; SUBUNIT VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; DRUG EFFICACY; ENTEROVIRUS 71; FEMALE; IMMUNIZATION; LIVER; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SALMONELLA TYPHIMURIUM; SPLEEN; SURVIVAL; VIRULENCE; VIRUS INFECTION;

ANIMALS; ANIMALS, NEWBORN; ANTIBODIES, VIRAL; BACTERIAL PROTEINS; CAPSID PROTEINS; CHILD; COLONY COUNT, MICROBIAL; ENTEROVIRUS INFECTIONS; FEMALE; HUMANS; HYPERSENSITIVITY, DELAYED; IMMUNITY, MATERNALLY-ACQUIRED; LIVER; LYMPHOCYTES; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; PLASMIDS; PROMOTER REGIONS (GENETICS); SALMONELLA TYPHI; SPLEEN; VACCINES, ATTENUATED; VACCINES, SUBUNIT; VIRAL VACCINES;

HUMAN ENTEROVIRUS 71; SALMONELLA; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR TYPHIMURIUM;

EID: 33746436595     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2006.01.021     Document Type: Article

References (29)

1. Schmidt N.J., Lennette E.H., and Ho H.H. An apparently new enterovirus isolated from patients with disease of the central nervous system. J. Infect. Dis. 129 (1974) 304-309
2. Tagaya I., Takayama R., and Hagiwara A. A large-scale epidemic of hand, foot and mouth disease associated with enterovirus 71 infection in Japan in 1978. Jpn. J. Med. Sci. Biol. 34 (1981) 191-196
3. Chumakov K.M., Lavrova I.K., Martianova L.I., Korolev M.B., Bashkirtsev V.N., and Voroshilova M.K. Investigation of physicochemical properties of Bulgarian strain 258 of enterovirus type 71. Arch. Virol. 60 (1979) 359-362
4. Ho M., Chen E.R., Hsu K.H., Twu S.J., Chen K.T., Tsai S.F., Wang J.R., and Shih S.R. An epidemic of enterovirus 71 infection in Taiwan. Taiwan Enterovirus Epidemic Working Group. N. Engl. J. Med. 341 (1999) 929-935
5. da Silva E.E., Winkler M.T., and Pallansch M.A. Role of enterovirus 71 in acute flaccid paralysis after the eradication of poliovirus in Brazil. Emerg. Infect. Dis. 2 (1996) 231-233
6. Cardenas L., and Clements J.D. Oral immunization using live attenuated Salmonella spp. as carriers of foreign antigens. Clin. Microbiol. Rev. 5 (1992) 328-342
7. Chatfield S.N., Roberts M., Li J., Starns A., and Dougan G. The use of live attenuated Salmonella typhimurium on the subsequent colonization of swine by the wild-type parent strain. Vet. Microbiol. 31 (1994) 207-220
8. Hoiseth S.K., and Stocker B.A. Aromatic-dependent Salmonella typhimurium are non-virulent and are effective live vaccines. Nature 291 (1981) 238-239
9. Killar L.M., and Eisenstein T.K. Immunity to Salmonella typhimurium infection in C3H/HeJ and C3H/HeNCrBR mice: studies with an aromatic-dependent live S. typhimurium strain as a vaccine. Infect. Immun. 47 (1985) 605-612
10. Maskell D.J., Sweeney K.J., O'Callaghan D., Hormaeche C.E., Liew F.Y., and Dougan G. Salmonella typhimurium aroA mutants as carriers of the Escherichia coli heat-labile enterotoxin B subunit to the murine systemic and secretory immune systems. Microb. Pathog. 2 (1987) 211-221
11. Dougan G., Chatfield S.N., Pickard D., Bester J., O'Callaghan D., and Maskell D.J. Construction and characterization of vaccine strains of Salmonella harboring mutations in two different aro genes. J. Infect. Dis. 58 (1988) 1329-1335
12. Linde K. Preparation of stable Salmonella vaccine strains through combination of 2 independently attenuating markers with no limitation on growth. Arch. Exp. Veterinarmed. 34 (1980) 19-32
13. Medina E., Paglia P., Nikolaus T., Müller A., Hensel M., and Guzmán C.A. Pathogenicity island 2 mutants of Salmonella typhimurium are efficient carriers for heterologous antigens and enable modulation of immune responses. Infect. Immun. 67 (1999) 1093-1099
14. Shih S.R., Li Y.S., Chiou C.C., Suen P.C., Lin T.Y., Chang L.Y., Huang Y.C., Tsao K.C., Ning H.C., Wu T.Z., and Chan E.C. Expression of capsid protein VP1 for use as antigen for the diagnosis of enterovirus 71 infection. J. Med. Virol. 61 (2000) 228-234
15. Dunstan S.J., Simmons C.P., and Strugnell R.A. Use of in vivo-regulated promoters to deliver antigens from attenuated Salmonella enterica var Typhimurium. Infect. Immun. 67 (1999) 5133-5141
16. Sizemore D.R., Fink P.S., Ou J.T., Baron L., Kopecko D.J., and Warren R.L. Tn5 mutagenesis of the Salmonella typhimurium 100-kb plasmid: definition of new virulence regions. Microb. Pathog. 10 (1991) 493-499
17. von Zeipel G. Neutralization of aggregated strains of enterovirus 71 and echovirus type 5 in RD and Vero or GMK-AH1 cells. Acta Pathol. Microbiol. Scand. B 87b (1979) 71-73
18. Sadoff J.C., Ballou W.R., Baron L.S., Majarian W.R., Brey R.N., Hockmeyer W.T., Young J.F., Cryz S.J., Ou J.T., Lowell G.H., and Chulay J.D. Oral Salmonella typhimurium vaccine expressing circumsporozoite protein protects against malaria. Science 240 (1988) 336-338
19. Wu C.N., Lin Y.C., Fann C., Jiao N.S., Shih S.R., and Ho M.S. Protection against lethal enterovirus 71 infection in newborn mice by passive immunization with subunit VP1 vaccines and inactivated virus. Vaccine 20 (2001) 895-904
20. Chatfield S.N., Charles I.G., Makoff A.J., Oxer M.D., Dougan G., Pickard D., Slater D., and Fairweather N.F. Use of the nirB promoter to direct the stable expression of heterologous antigens in Salmonella oral vaccine strains: development of a single-dose oral tetanus vaccine. Biotechnology 10 (1992) 888-892
21. Barry E.M., Gomez-Duarte O., Chatfield S.N., Rappuoli R., Pizza M., Losonsky G., Galen J., and Levine M.M. Expression and immunogenicity of pertussis toxin S1 subunit-tetanus toxin fragment C fusions in Salmonella typhi vaccine strain CVD 908. Infect. Immun. 64 (1996) 4172-4181
22. Chabalgoity J.A., Harrison J.A., Esteves A., Demarco de Hormaeche R., Ehrlich R., Khan C.M., and Hormaeche C.E. Expression and immunogenicity of an Echinococcus granulosus fatty acid-binding protein in live attenuated Salmonella vaccine strains. Infect. Immun. 65 (1997) 2402-2412
23. Hohmann E.L., Oletta C.A., Loomis W.P., and Miller S.I. Macrophage-inducible expression of a model antigen in Salmonella typhimurium enhances immunogenicity. Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 2904-2908
24. Guiney D.G., Fang F.C., Krause M., Libby S., Buchmeier N.A., and Fierer J. Biology and clinical significance of virulence plasmids in Salmonella serovars. Clin. Infect. Dis. 21 Suppl. 2 (1995) 146-151
25. Chiu C.H., Lin T.Y., and Ou J.T. Prevalence of the virulence plasmids of nontyphoid Salmonella in the serovars isolated from humans and their association with bacteremia. Microbiol. Immunol. 43 (1999) 899-903
26. Yu C.K., Chen C.C., Chen C.L., Wang J.R., Liu C.C., Yan J.J., and Su I.J. Neutralizing antibody provided protection against enterovirus type 71 lethal challenge in neonatal mice. J. Biomed. Sci. 7 (2000) 523-528
27. Bao J.X., and Clements J.D. Prior immunological experience potentiates the subsequent antibody response when Salmonella strains are used as vaccine carriers. Infect. Immun. 59 (1991) 3841-3845
28. Whittle B.L., and Verma N.K. The immune response to a B-cell epitope delivered by Salmonella is enhanced by prior immunological experience. Vaccine 15 (1997) 1737-1740
29. Jespersgaard C., Zhang P., Hajishengallis G., Russell M.W., and Michalek S.M. Effect of attenuated Salmonella enterica serovar Typhimurium expressing a Streptococcus mutans antigen on secondary responses to the cloned protein. Infect. Immun. 69 (2001) 6604-6611